Epstein Secrets

gistics hurdles, and to distribute hundreds of millions of shots equitably." The Post refers to the National Academies of Sciences, Engineering and Medicine's tentative vaccine distribution framework, which "envisions a phased approach, to begin with a Phase 1 'jumpstart' group: high-risk health workers

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

gistics hurdles, and to distribute hundreds of millions of shots equitably." The Post refers to the National Academies of Sciences, Engineering and Medicine's tentative vaccine distribution framework, which "envisions a phased approach, to begin with a Phase 1 'jumpstart' group: high-risk health workers

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

basic safety and efficacy data. The most comprehensive list of unapproved drugs is not maintained by the FDA, but rather by the National Library of Medicine, which identities 88,212 drugs that have been reported to the FDA. Many of these drugs are routinely prescribed by health care professionals and pur

ed in prohibitive and avoidable excess mortality and morbidity rates. One of the more recent drug approvals that was later withdrawn was in 2004 for Merck's anti- inflammatory drug Rofecoxib (Vioxx •) which has been conservatively attributed with over 38,000 deaths in the US, and 60,000 worldwide. The